By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cisbio Bioassays and the Functional Genomics Institute (IGF) have used a French government grant of €900, 000 ($1.2 million) to start a new research and development program that will use Cisbio's Tag-lite technology to identify and create potential drugs for nervous system disorders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."